Tolerability, safety and intermediary pharmacological effects of cilostazol and isosorbide mononitrate, alone and combined, in patients with lacunar ischaemic stroke: The LACunar Intervention-1 (LACI-1) trial, a randomised clinical trial

BACKGROUND: Lacunar stroke, a frequent clinical manifestation of small vessel disease (SVD), differs pathologically from other ischaemic stroke subtypes and has no specific long-term secondary prevention. Licenced drugs, isosorbide mononitrate (ISMN) and cilostazol, have relevant actions to prevent...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :EClinicalMedicine
Главные авторы: Blair, Gordon W., Appleton, Jason P., Flaherty, Katie, Doubal, Fergus, Sprigg, Nikola, Dooley, Richard, Richardson, Carla, Hamilton, Iona, Law, Zhe Kang, Shi, Yulu, Stringer, Michael S., Thrippleton, Michael J., Boyd, Julia, Shuler, Kirsten, Bath, Philip M., Wardlaw, Joanna M.
Формат: Artigo
Язык:Inglês
Опубликовано: Elsevier 2019
Предметы:
Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6611094/
https://ncbi.nlm.nih.gov/pubmed/31317131
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2019.04.001
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы